Remus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Cash & Equivalents	459.93	268.68	30.38	11.49	8.31	11.98
Short-Term Investments	-	24.77	-	-	-	-
Cash & Short-Term Investments	459.93	293.45	30.38	11.49	8.31	11.98
Cash Growth	-	865.87%	164.51%	38.30%	-30.68%	-
Receivables	596.76	1,145	48.48	29.15	36.04	16.27
Inventory	378.58	428.81	2.87	15.89	11.51	4.37
Prepaid Expenses	-	0.4	0.49	0.07	-	-
Other Current Assets	277.85	229.96	31.22	20.34	19.15	15
Total Current Assets	1,713	2,097	113.44	76.94	75	47.61
Property, Plant & Equipment	45.57	22.75	25.13	3.09	3.92	5.01
Long-Term Investments	205.49	205.49	206.16	30.68	0.67	-
Goodwill	93.37	93.37	-	-	-	-
Other Intangible Assets	0.21	0.28	0.5	-	-	-
Long-Term Deferred Tax Assets	10.29	8.41	1.27	0.41	0.6	0.27
Other Long-Term Assets	145.86	145.04	0.12	47.49	30.31	0.14
Total Assets	2,214	2,573	346.61	158.6	110.5	53.04
Accounts Payable	376.54	937.03	35.31	46.73	51.59	13.09
Accrued Expenses	35.6	9.31	8.61	2.75	9.63	1.33
Short-Term Debt	171.21	83.38	6.38	-	-	-
Current Portion of Long-Term Debt	-	2.14	2.16	0.93	0.87	0.8
Current Income Taxes Payable	-	14.32	6.75	4.71	3.58	0.75
Other Current Liabilities	360.2	448.64	22.41	36.71	11.24	13.28
Total Current Liabilities	943.54	1,495	81.62	91.84	76.92	29.25
Long-Term Debt	37.24	29.95	70.89	0.99	1.92	2.79
Other Long-Term Liabilities	-	0.4	-	-	-	-
Total Liabilities	985.4	1,529	155.26	92.82	80.04	32.83
Common Stock	58.92	14.73	10.85	10	0.1	0.1
Additional Paid-In Capital	-	504.74	41.65	-	-	-
Retained Earnings	-	348.33	138.86	55.78	30.36	20.1
Comprehensive Income & Other	945.96	0.77	-	-	-	-
Total Common Equity	1,005	868.57	191.36	65.78	30.46	20.2
Minority Interest	223.64	174.77	-	-	-	-
Shareholders' Equity	1,229	1,043	191.36	65.78	30.46	20.2
Total Liabilities & Equity	2,214	2,573	346.61	158.6	110.5	53.04
Total Debt	208.45	115.47	79.43	1.92	2.79	3.59
Net Cash (Debt)	251.48	177.98	-49.05	9.57	5.52	8.39
Net Cash Growth	-	-	-	73.48%	-34.24%	-
Net Cash Per Share	42.67	31.40	-12.01	2.39	1.38	2.10
Filing Date Shares Outstanding	5.89	5.89	4.34	4.34	4	4
Total Common Shares Outstanding	5.89	5.89	4.34	4.34	4	4
Working Capital	769.59	602.58	31.82	-14.9	-1.91	18.36
Book Value Per Share	170.55	147.41	44.09	15.16	7.62	5.05
Tangible Book Value	911.3	774.93	190.85	65.78	30.46	20.2
Tangible Book Value Per Share	154.67	131.52	43.98	15.16	7.62	5.05
Buildings	-	3.28	3.28	-	-	-
Machinery	-	37.56	31.07	7.89	7.18	6.52
Construction In Progress	-	0.09	0.22	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.